## **Core Concept**
The question tests knowledge of opioid pharmacology, specifically the properties of various opioid agonists. The ideal drug described has high oral bioavailability, equipotent analgesia to morphine, a longer duration of action, and milder withdrawal symptoms.

## **Why the Correct Answer is Right**
Methadone is a full agonist at opioid receptors, specifically at the mu (μ) opioid receptor, which is responsible for its analgesic effects. It has excellent oral bioavailability (>70-80%), making it effective when given orally. Methadone's analgesic potency is comparable to morphine, but it has a longer duration of action due to its high lipid solubility and large volume of distribution, allowing it to accumulate in tissues and be released slowly. Additionally, methadone has a slower onset of physical dependence and milder withdrawal symptoms compared to shorter-acting opioids like morphine.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Buprenorphine is a partial agonist at the mu (μ) opioid receptor, not a full agonist. While it does have a lower risk of overdose and milder withdrawal symptoms, its partial agonist activity and ceiling effect on respiratory depression make it different from a full agonist like methadone.
- **Option B:** Fentanyl is a potent, short-acting opioid agonist with a rapid onset of action. It does not have a longer duration of action compared to morphine and is not known for milder withdrawal symptoms.
- **Option C:** This option might seem plausible but does not match the profile given for methadone.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that methadone, besides being used for pain management, is also utilized in the treatment of opioid dependence due to its ability to reduce withdrawal symptoms and cravings. Its long half-life allows for once-daily dosing, which aids in medication adherence.

## **Correct Answer: D. Methadone**